HCPCS Code Details - J0576

HCPCS Level II Code
Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J0576
Description

Long description:
Injection, buprenorphine extended-release (brixadi), 1 mg

Short description:
Inj buprenorph (brixadi) 1mg

HCPCS Modifier1
HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1E - Other drugs
HCPCS Action code D - Discontinue procedure or modifier code
Type of service 1 - Medical care
Effective date Effective Apr 01, 2024
Date added Added Jan 01, 2024
Termination date Mar 31, 2024
HCPCS Coding Procedures
  HCPCS Code J0576 has been discontinued effective Apr 01, 2024.

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
NU” identifies the hospital bed as new equipment

See also

  • HCPCS J0575 · Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine

  • HCPCS C9154 · Injection, buprenorphine extended-release (brixadi), 1 mg

  • HCPCS J0577 · Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy

  • HCPCS Q9991 · Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg

  • HCPCS Q9992 · Injection, buprenorphine extended-release (sublocade), greater than 100 mg


1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”